H. R. 6—206 
‘‘(B) assistance in receiving the appropriate benefits 
to aid the parent or guardian in recovery; 
‘‘(C) services to assist the parent or guardian in 
prioritizing issues identified in assessments, establishing 
goals for resolving such issues that are consistent with 
the goals of the treatment provider, child welfare agency, 
courts, and other agencies involved with the parent or 
guardian or their children, and making a coordinated plan 
for achieving such goals; 
‘‘(D) home visiting services coordinated with the child 
welfare agency and treatment provider involved with the 
parent or guardian or their children; 
‘‘(E) case management services to remove barriers for 
the parent or guardian to participate and continue in treat-
ment, as well as to re-engage a parent or guardian who 
is not participating or progressing in treatment; 
‘‘(F) access to services needed to monitor the parent’s 
or guardian’s compliance with program requirements; 
‘‘(G) frequent reporting between the treatment pro-
vider, child welfare agency, courts, and other agencies 
involved with the parent or guardian or their children 
to ensure appropriate information on the parent’s or guard-
ian’s status is available to inform decision-making; and 
‘‘(H) assessments and recommendations provided by 
a recovery coach to the child welfare caseworker responsible 
for documenting the parent’s or guardian’s progress in 
treatment and recovery as well as the status of other 
areas identified in the treatment plan for the parent or 
guardian, including a recommendation regarding the 
expected safety of the child if the child is returned to 
the custody of the parent or guardian that can be used 
by the caseworker and a court to make permanency 
decisions regarding the child. 
‘‘(3) RESPONSIBILITIES OF THE SECRETARY.— 
‘‘(A) IN GENERAL.—The Secretary shall, through a grant 
or contract with 1 or more entities, conduct and evaluate 
the family recovery and reunification program under the 
project. 
‘‘(B) REQUIREMENTS.—In identifying 1 or more entities 
to conduct the evaluation of the family recovery and reunifi-
cation program, the Secretary shall— 
‘‘(i) determine that the area or areas in which 
the program will be conducted have sufficient sub-
stance use disorder treatment providers and other 
resources (other than those provided with funds made 
available to carry out the project) to successfully con-
duct the program; 
‘‘(ii) determine that the area or areas in which 
the program will be conducted have enough potential 
program participants, and will serve a sufficient 
number of parents or guardians and their children, 
so as to allow for the formation of a control group, 
evaluation results to be adequately powered, and 
preliminary results of the evaluation to be available 
within 4 years of the program’s implementation; 
‘‘(iii) provide the entity or entities with technical 
assistance for the program design, including by
H. R. 6—207 
working with 1 or more entities that are or have been 
involved in recovery coaching programs that have been 
rigorously evaluated and shown to increase family 
reunification and protect children so as to make sure 
the program conducted under the project adheres 
closely to the elements and protocol determined to 
be most effective in such other recovery coaching pro-
grams; 
‘‘(iv) assist the entity or entities in securing ade-
quate coaching, treatment, child welfare, court, and 
other resources needed to successfully conduct the 
family recovery and reunification program under the 
project; and 
‘‘(v) ensure the entity or entities will be able to 
monitor the impacts of the program in the area or 
areas in which it is conducted for at least 5 years 
after parents or guardians and their children are ran-
domly assigned to participate in the program or to 
be part of the program’s control group. 
‘‘(4) EVALUATION REQUIREMENTS.— 
‘‘(A) IN GENERAL.—The Secretary, in consultation with 
the entity or entities conducting the family recovery and 
reunification program under the project, shall conduct an 
evaluation to determine whether the program has been 
implemented effectively and resulted in improvements for 
children and families. The evaluation shall have 3 compo-
nents: a pilot phase, an impact study, and an implementa-
tion study. 
‘‘(B) PILOT PHASE.—The pilot phase component of the 
evaluation shall consist of the Secretary providing technical 
assistance to the entity or entities conducting the family 
recovery and reunification program under the project to 
ensure— 
‘‘(i) the program’s implementation adheres closely 
to the elements and protocol determined to be most 
effective in other recovery coaching programs that have 
been rigorously evaluated and shown to increase family 
reunification and protect children; and 
‘‘(ii) random assignment of parents or guardians 
and their children to be participants in the program 
or to be part of the program’s control group is being 
carried out. 
‘‘(C) IMPACT STUDY.—The impact study component of 
the evaluation shall determine the impacts of the family 
recovery and reunification program conducted under the 
project on the parents and guardians and their children 
participating in the program. The impact study component 
shall— 
‘‘(i) be conducted using an experimental design 
that uses a random assignment research methodology; 
‘‘(ii) consistent with previous studies of other 
recovery coaching programs that have been rigorously 
evaluated and shown to increase family reunification 
and protect children, measure outcomes for parents 
and guardians and their children over multiple time 
periods, including for a period of 5 years; and
H. R. 6—208 
‘‘(iii) include measurements of family stability and 
parent, guardian, and child safety for program partici-
pants and the program control group that are con-
sistent with measurements of such factors for partici-
pants and control groups from previous studies of other 
recovery coaching programs so as to allow results of 
the impact study to be compared with the results of 
such prior studies, including with respect to compari-
sons between program participants and the program 
control group regarding— 
‘‘(I) safe family reunification; 
‘‘(II) time to reunification; 
‘‘(III) permanency (such as through measures 
of reunification, adoption, or placement with 
guardians); 
‘‘(IV) safety (such as through measures of sub-
sequent maltreatment); 
‘‘(V) parental or guardian treatment persist-
ence and engagement; 
‘‘(VI) parental or guardian substance use; 
‘‘(VII) juvenile delinquency; 
‘‘(VIII) cost; and 
‘‘(IX) other measurements agreed upon by the 
Secretary and the entity or entities operating the 
family recovery and reunification program under 
the project. 
‘‘(D) IMPLEMENTATION
STUDY.—The implementation 
study component of the evaluation shall be conducted 
concurrently with the conduct of the impact study compo-
nent and shall include, in addition to such other informa-
tion as the Secretary may determine, descriptions and anal-
yses of— 
‘‘(i) the adherence of the family recovery and 
reunification program conducted under the project to 
other recovery coaching programs that have been rigor-
ously evaluated and shown to increase family reunifica-
tion and protect children; and 
‘‘(ii) the difference in services received or proposed 
to be received by the program participants and the 
program control group. 
‘‘(E) REPORT.—The Secretary shall publish on an inter-
net website maintained by the Secretary the following 
information: 
‘‘(i) A report on the pilot phase component of the 
evaluation. 
‘‘(ii) A report on the impact study component of 
the evaluation. 
‘‘(iii) A report on the implementation study compo-
nent of the evaluation. 
‘‘(iv) A report that includes— 
‘‘(I) analyses of the extent to which the pro-
gram has resulted in increased reunifications, 
increased permanency, case closures, net savings 
to the State or States involved (taking into account 
both costs borne by States and the Federal govern-
ment), or other outcomes, or if the program did 
not produce such outcomes, an analysis of why
H. R. 6—209 
the replication of the program did not yield such 
results; 
‘‘(II) if, based on such analyses, the Secretary 
determines the program should be replicated, a 
replication plan; and 
‘‘(III) such recommendations for legislation 
and administrative action as the Secretary deter-
mines appropriate. 
‘‘(5) APPROPRIATION.—In addition to any amounts otherwise 
made available to carry out this subpart, out of any money 
in the Treasury of the United States not otherwise appro-
priated, there are appropriated $15,000,000 for fiscal year 2019 
to carry out the project, which shall remain available through 
fiscal year 2026.’’. 
(b) CLARIFICATION OF PAYER OF LAST RESORT APPLICATION TO 
CHILD
WELFARE
PREVENTION
AND
FAMILY
SERVICES.—Section 
471(e)(10) of the Social Security Act (42 U.S.C. 671(e)(10)), as added 
by section 50711(a)(2) of division E of Public Law 115–123, is 
amended— 
(1) in subparagraph (A), by inserting ‘‘, nor shall the provi-
sion of such services or programs be construed to permit the 
State to reduce medical or other assistance available to a 
recipient of such services or programs’’ after ‘‘under this Act’’; 
and 
(2) by adding at the end the following: 
‘‘(C) PAYER
OF
LAST
RESORT.—In carrying out its 
responsibilities to ensure access to services or programs 
under this subsection, the State agency shall not be consid-
ered to be a legally liable third party for purposes of 
satisfying a financial commitment for the cost of providing 
such services or programs with respect to any individual 
for whom such cost would have been paid for from another 
public or private source but for the enactment of this 
subsection (except that whenever considered necessary to 
prevent a delay in the receipt of appropriate early interven-
tion services by a child or family in a timely fashion, 
funds provided under section 474(a)(6) may be used to 
pay the provider of services or programs pending 
reimbursement from the public or private source that has 
ultimate responsibility for the payment).’’. 
(c) EFFECTIVE DATE.—The amendments made by subsection 
(b) shall take effect as if included in section 50711 of division 
E of Public Law 115–123. 
SEC. 8083. BUILDING CAPACITY FOR FAMILY-FOCUSED RESIDENTIAL 
TREATMENT. 
(a) DEFINITIONS.—In this section: 
(1) ELIGIBLE ENTITY.—The term ‘‘eligible entity’’ means a 
State, county, local, or tribal health or child welfare agency, 
a private nonprofit organization, a research organization, a 
treatment service provider, an institution of higher education 
(as defined under section 101 of the Higher Education Act 
of 1965 (20 U.S.C. 1001)), or another entity specified by the 
Secretary. 
(2) FAMILY-FOCUSED RESIDENTIAL TREATMENT PROGRAM.— 
The term ‘‘family-focused residential treatment program’’ means 
a trauma-informed residential program primarily for substance
H. R. 6—210 
use disorder treatment for pregnant and postpartum women 
and parents and guardians that allows children to reside with 
such women or their parents or guardians during treatment 
to the extent appropriate and applicable. 
(3) SECRETARY.—The term ‘‘Secretary’’ means the Secretary 
of Health and Human Services. 
(b) SUPPORT
FOR
THE
DEVELOPMENT
OF
EVIDENCE-BASED 
FAMILY-FOCUSED RESIDENTIAL TREATMENT PROGRAMS.— 
(1) AUTHORITY
TO
AWARD
GRANTS.—The Secretary shall 
award grants to eligible entities for purposes of developing, 
enhancing, or evaluating family-focused residential treatment 
programs to increase the availability of such programs that 
meet the requirements for promising, supported, or well-sup-
ported practices specified in section 471(e)(4)(C) of the Social 
Security Act (42 U.S.C. 671(e)(4)(C))) (as added by the Family 
First Prevention Services Act enacted under title VII of division 
E of Public Law 115–123). 
(2) 
EVALUATION
REQUIREMENT.—The 
Secretary 
shall 
require any evaluation of a family-focused residential treatment 
program by an eligible entity that uses funds awarded under 
this section for all or part of the costs of the evaluation be 
designed to assist in the determination of whether the program 
may qualify as a promising, supported, or well-supported prac-
tice in accordance with the requirements of such section 
471(e)(4)(C). 
(c) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 
to be appropriated to the Secretary to carry out this section, 
$20,000,000 for fiscal year 2019, which shall remain available 
through fiscal year 2023. 
Subtitle H—Reauthorizing and Extending 
Grants for Recovery From Opioid Use 
Programs 
SEC. 8091. SHORT TITLE. 
This subtitle may be cited as the ‘‘Reauthorizing and Extending 
Grants for Recovery from Opioid Use Programs Act of 2018’’ or 
the ‘‘REGROUP Act of 2018’’. 
SEC. 8092. REAUTHORIZATION OF THE COMPREHENSIVE OPIOID 
ABUSE GRANT PROGRAM. 
Section 1001(a)(27) of the Omnibus Crime Control and Safe 
Streets Act of 1968 (34 U.S.C. 10261(a)(27)) is amended by striking 
‘‘through 2021’’ and inserting ‘‘and 2018, and $330,000,000 for each 
of fiscal years 2019 through 2023’’. 
Subtitle I—Fighting Opioid Abuse in 
Transportation 
SEC. 8101. SHORT TITLE. 
This subtitle may be cited as the ‘‘Fighting Opioid Abuse in 
Transportation Act’’.
H. R. 6—211 
SEC. 8102. ALCOHOL AND CONTROLLED SUBSTANCE TESTING OF 
MECHANICAL EMPLOYEES. 
(a) IN GENERAL.—Not later than 2 years after the date of 
enactment of this Act, the Secretary of Transportation shall publish 
a rule in the Federal Register revising the regulations promulgated 
under section 20140 of title 49, United States Code, to cover all 
employees of railroad carriers who perform mechanical activities. 
(b) DEFINITION OF MECHANICAL ACTIVITIES.—For the purposes 
of the rule under subsection (a), the Secretary shall define the 
term ‘‘mechanical activities’’ by regulation. 
SEC. 8103. DEPARTMENT OF TRANSPORTATION PUBLIC DRUG AND 
ALCOHOL TESTING DATABASE. 
(a) IN GENERAL.—Subject to subsection (c), the Secretary of 
Transportation shall— 
(1) not later than March 31, 2019, establish and make 
publicly available on its website a database of the drug and 
alcohol testing data reported by employers for each mode of 
transportation; and 
(2) update the database annually. 
(b) CONTENTS.—The database under subsection (a) shall 
include, for each mode of transportation— 
(1) the total number of drug and alcohol tests by type 
of substance tested; 
(2) the drug and alcohol test results by type of substance 
tested; 
(3) the reason for the drug or alcohol test, such as pre- 
employment, random, post-accident, reasonable suspicion or 
cause, return-to-duty, or follow-up, by type of substance tested; 
and 
(4) the number of individuals who refused testing. 
(c) COMMERCIALLY
SENSITIVE
DATA.—The Department of 
Transportation shall not release any commercially sensitive data 
or personally identifiable data furnished by an employer under 
this section unless the data is aggregated or otherwise in a form 
that does not identify the employer providing the data. 
(d) SAVINGS CLAUSE.—Nothing in this section may be construed 
as limiting or otherwise affecting the requirements of the Secretary 
of Transportation to adhere to requirements applicable to confiden-
tial business information and sensitive security information, con-
sistent with applicable law. 
SEC. 8104. GAO REPORT ON DEPARTMENT OF TRANSPORTATION’S 
COLLECTION AND USE OF DRUG AND ALCOHOL TESTING 
DATA. 
(a) IN GENERAL.—Not later than 2 years after the date the 
Department of Transportation public drug and alcohol testing data-
base is established under section 8103, the Comptroller General 
of the United States shall— 
(1) review the Department of Transportation Drug and 
Alcohol Testing Management Information System; and 
(2) submit to the Committee on Commerce, Science, and 
Transportation of the Senate and the Committee on Transpor-
tation and Infrastructure of the House of Representatives a 
report on the review, including recommendations under sub-
section (c). 
(b) CONTENTS.—The report under subsection (a) shall include—
H. R. 6—212 
(1) a description of the process the Department of Transpor-
tation uses to collect and record drug and alcohol testing data 
submitted by employers for each mode of transportation; 
(2) an assessment of whether and, if so, how the Depart-
ment of Transportation uses the data described in paragraph 
(1) in carrying out its responsibilities; and 
(3) an assessment of the Department of Transportation 
public drug and alcohol testing database under section 8103. 
(c) RECOMMENDATIONS.—The report under subsection (a) may 
include recommendations regarding— 
(1) how the Department of Transportation can best use 
the data described in subsection (b)(1); 
(2) any improvements that could be made to the process 
described in subsection (b)(1); 
(3) whether and, if so, how the Department of Transpor-
tation public drug and alcohol testing database under section 
8103 could be made more effective; and 
(4) such other recommendations as the Comptroller General 
considers appropriate. 
SEC. 8105. TRANSPORTATION WORKPLACE DRUG AND ALCOHOL 
TESTING PROGRAM; ADDITION OF FENTANYL AND OTHER 
SUBSTANCES. 
(a) MANDATORY GUIDELINES FOR FEDERAL WORKPLACE DRUG 
TESTING PROGRAMS.— 
(1) IN GENERAL.—Not later than 180 days after the date 
of enactment of this Act, the Secretary of Health and Human 
Services shall— 
(A) determine whether a revision of the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs 
to expand the opiate category on the list of authorized 
substance testing to include fentanyl is justified, based 
on the reliability and cost-effectiveness of available testing; 
and 
(B) consider whether to include with the determination 
under subparagraph (A) a separate determination on 
whether a revision of the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs to expand the list of 
substances authorized for testing to include any other drugs 
or other substances listed in schedule I and II of section 
202 of the Controlled Substances Act (21 U.S.C. 812) is 
justified based on the criteria described in subparagraph 
(A). 
(2) REVISION OF GUIDELINES.—If an expansion of the sub-
stance list is determined to be justified under paragraph (1), 
the Secretary of Health and Human Services shall— 
(A) notify the Committee on Commerce, Science, and 
Transportation of the Senate and the Committee on 
Transportation and Infrastructure of the House of Rep-
resentatives of the determination; and 
(B) publish in the Federal Register, not later than 
18 months after the date of the determination under that 
paragraph, a final notice of the revision of the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs 
to expand the list of substances authorized to be tested 
to include the substance or substances determined to be 
justified for inclusion.
H. R. 6—213 
(3) REPORT.—If an expansion of the substance list is deter-
mined not to be justified under paragraph (1), the Secretary 
of Health and Human Services shall submit to the Committee 
on Commerce, Science, and Transportation of the Senate and 
the Committee on Transportation and Infrastructure of the 
House of Representatives a report explaining, in detail, the 
reasons the expansion of the list of authorized substances is 
not justified. 
(b) DEPARTMENT OF TRANSPORTATION DRUG-TESTING PANEL.— 
If an expansion is determined to be justified under subsection 
(a)(1), the Secretary of Transportation shall publish in the Federal 
Register, not later than 18 months after the date the final notice 
is published under subsection (a)(2), a final rule revising part 40 
of title 49, Code of Federal Regulations, to include such substances 
in the Department of Transportation’s drug-testing panel, consistent 
with the Mandatory Guidelines for Federal Workplace Drug Testing 
Programs as revised by the Secretary of Health and Human Services 
under subsection (a). 
(c) SAVINGS PROVISION.—Nothing in this section may be con-
strued as— 
(1) delaying the publication of the notices described in 
sections 8106 and 8107 of this Act until the Secretary of Health 
and Human Services makes a determination or publishes a 
notice under this section; or 
(2) limiting or otherwise affecting any authority of the 
Secretary of Health and Human Services or the Secretary of 
Transportation to expand the list of authorized substance 
testing to include an additional substance. 
SEC. 8106. STATUS REPORTS ON HAIR TESTING GUIDELINES. 
(a) IN GENERAL.—Not later than 60 days after the date of 
enactment of this Act, and annually thereafter until the date that 
the Secretary of Health and Human Services publishes in the 
Federal Register a final notice of scientific and technical guidelines 
for hair testing in accordance with section 5402(b) of the Fixing 
America’s Surface Transportation Act (Public Law 114-94; 129 Stat. 
1312), the Secretary of Health and Human Services shall submit 
to the Committee on Commerce, Science, and Transportation of 
the Senate and the Committee on Transportation and Infrastructure 
of the House of Representatives a report on— 
(1) the status of the hair testing guidelines; 
(2) an explanation for why the hair testing guidelines have 
not been issued; and 
(3) an estimated date of completion of the hair testing 
guidelines. 
(b) REQUIREMENT.—To the extent practicable and consistent 
with the objective of the hair testing described in subsection (a) 
to detect illegal or unauthorized use of substances by the individual 
being tested, the final notice of scientific and technical guidelines 
under that subsection, as determined by the Secretary of Health 
and Human Services, shall eliminate the risk of positive test results, 
of the individual being tested, caused solely by the drug use of 
others and not caused by the drug use of the individual being 
tested.
H. R. 6—214 
SEC. 8107. MANDATORY GUIDELINES FOR FEDERAL WORKPLACE DRUG 
TESTING PROGRAMS USING ORAL FLUID. 
(a) DEADLINE.—Not later than December 31, 2018, the Sec-
retary of Health and Human Services shall publish in the Federal 
Register a final notice of the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs using Oral Fluid, based on the 
notice of proposed mandatory guidelines published in the Federal 
Register on May 15, 2015 (94 FR 28054). 
(b) REQUIREMENT.—To the extent practicable and consistent 
with the objective of the testing described in subsection (a) to 
detect illegal or unauthorized use of substances by the individual 
being tested, the final notice of scientific and technical guidelines 
under that subsection, as determined by the Secretary of Health 
and Human Services, shall eliminate the risk of positive test results, 
of the individual being tested, caused solely by the drug use of 
others and not caused by the drug use of the individual being 
tested. 
(c) RULE OF CONSTRUCTION.—Nothing in this section may be 
construed as requiring the Secretary of Health and Human Services 
to reissue a notice of proposed mandatory guidelines to carry out 
subsection (a). 
SEC. 8108. ELECTRONIC RECORDKEEPING. 
(a) DEADLINE.—Not later than 1 year after the date of enact-
ment of this Act, the Secretary of Health and Human Services 
shall— 
(1) ensure that each certified laboratory that requests 
approval for the use of completely paperless electronic Federal 
Drug Testing Custody and Control Forms from the National 
Laboratory Certification Program’s Electronic Custody and Con-
trol Form systems receives approval for those completely 
paperless electronic forms instead of forms that include any 
combination of electronic traditional handwritten signatures 
executed on paper forms; and 
(2) establish a deadline for a certified laboratory to request 
approval under paragraph (1). 
(b) SAVINGS CLAUSE.—Nothing in this section may be construed 
as limiting or otherwise affecting any authority of the Secretary 
of Health and Human Services to grant approval to a certified 
laboratory for use of completely paperless electronic Federal Drug 
Testing Custody and Control Forms, including to grant approval 
outside of the process under subsection (a). 
(c) ELECTRONIC SIGNATURES.—Not later than 18 months after 
the date of the deadline under subsection (a)(2), the Secretary 
of Transportation shall issue a final rule revising part 40 of title 
49, Code of Federal Regulations, to authorize, to the extent prac-
ticable, the use of electronic signatures or digital signatures 
executed to electronic forms instead of traditional handwritten sig-
natures executed on paper forms. 
SEC. 8109. STATUS REPORTS ON COMMERCIAL DRIVER’S LICENSE 
DRUG AND ALCOHOL CLEARINGHOUSE. 
(a) IN GENERAL.—Not later than 60 days after the date of 
enactment of this Act, and annually thereafter until the compliance 
date, the Administrator of the Federal Motor Carrier Safety 
Administration shall submit to the Committee on Commerce, 
Science, and Transportation of the Senate and the Committee on
H. R. 6—215 
Transportation and Infrastructure of the House of Representatives 
a status report on implementation of the final rule for the Commer-
cial Driver’s License Drug and Alcohol Clearinghouse (81 FR 87686), 
including— 
(1) an updated schedule, including benchmarks, for imple-
menting the final rule as soon as practicable, but not later 
than the compliance date; and 
(2) a description of each action the Federal Motor Carrier 
Safety Administration is taking to implement the final rule 
before the compliance date. 
(b) DEFINITION OF COMPLIANCE DATE.—In this section, the term 
‘‘compliance date’’ means the earlier of— 
(1) January 6, 2020; or 
(2) the date that the national clearinghouse required under 
section 31306a of title 49, United States Code, is operational. 
Subtitle J—Eliminating Kickbacks in 
Recovery 
SEC. 8121. SHORT TITLE. 
This subtitle may be cited as the ‘‘Eliminating Kickbacks in 
Recovery Act of 2018’’. 
SEC. 8122. CRIMINAL PENALTIES. 
(a) IN GENERAL.—Chapter 11 of title 18, United States Code, 
is amended by inserting after section 219 the following: 
‘‘§ 220. Illegal remunerations for referrals to recovery homes, 
clinical treatment facilities, and laboratories 
‘‘(a) OFFENSE.—Except as provided in subsection (b), whoever, 
with respect to services covered by a health care benefit program, 
in or affecting interstate or foreign commerce, knowingly and will-
fully— 
‘‘(1) solicits or receives any remuneration (including any 
kickback, bribe, or rebate) directly or indirectly, overtly or 
covertly, in cash or in kind, in return for referring a patient 
or patronage to a recovery home, clinical treatment facility, 
or laboratory; or 
‘‘(2) pays or offers any remuneration (including any kick-
back, bribe, or rebate) directly or indirectly, overtly or covertly, 
in cash or in kind— 
‘‘(A) to induce a referral of an individual to a recovery 
home, clinical treatment facility, or laboratory; or 
‘‘(B) in exchange for an individual using the services 
of that recovery home, clinical treatment facility, or labora-
tory, 
shall be fined not more than $200,000, imprisoned not more than 
10 years, or both, for each occurrence. 
‘‘(b) APPLICABILITY.—Subsection (a) shall not apply to— 
‘‘(1) a discount or other reduction in price obtained by 
a provider of services or other entity under a health care 
benefit program if the reduction in price is properly disclosed 
and appropriately reflected in the costs claimed or charges 
made by the provider or entity; 
‘‘(2) a payment made by an employer to an employee or 
independent contractor (who has a bona fide employment or
H. R. 6—216 
contractual relationship with such employer) for employment, 
if the employee’s payment is not determined by or does not 
vary by— 
‘‘(A) the number of individuals referred to a particular 
recovery home, clinical treatment facility, or laboratory; 
‘‘(B) the number of tests or procedures performed; or 
‘‘(C) the amount billed to or received from, in part 
or in whole, the health care benefit program from the 
individuals referred to a particular recovery home, clinical 
treatment facility, or laboratory; 
‘‘(3) a discount in the price of an applicable drug of a 
manufacturer that is furnished to an applicable beneficiary 
under the Medicare coverage gap discount program under sec-
tion 1860D–14A(g) of the Social Security Act (42 U.S.C. 1395w– 
114a(g)); 
‘‘(4) a payment made by a principal to an agent as com-
pensation for the services of the agent under a personal services 
and management contract that meets the requirements of sec-
tion 1001.952(d) of title 42, Code of Federal Regulations, as 
in effect on the date of enactment of this section; 
‘‘(5) 
a 
waiver 
or 
discount 
(as 
defined 
in 
section 
1001.952(h)(5) of title 42, Code of Federal Regulations, or any 
successor regulation) of any coinsurance or copayment by a 
health care benefit program if— 
‘‘(A) the waiver or discount is not routinely provided; 
and 
‘‘(B) the waiver or discount is provided in good faith; 
‘‘(6) a remuneration described in section 1128B(b)(3)(I) of 
the Social Security Act (42 U.S.C. 1320a–7b(b)(3)(I)); 
‘‘(7) a remuneration made pursuant to an alternative pay-
ment model (as defined in section 1833(z)(3)(C) of the Social 
Security Act) or pursuant to a payment arrangement used 
by a State, health insurance issuer, or group health plan if 
the Secretary of Health and Human Services has determined 
that such arrangement is necessary for care coordination or 
value-based care; or 
‘‘(8) any other payment, remuneration, discount, or reduc-
tion as determined by the Attorney General, in consultation 
with the Secretary of Health and Human Services, by regula-
tion. 
‘‘(c) REGULATIONS.—The Attorney General, in consultation with 
the Secretary of Health and Human Services, may promulgate 
regulations to clarify the exceptions described in subsection (b). 
‘‘(d) PREEMPTION.— 
‘‘(1) FEDERAL LAW.—This section shall not apply to conduct 
that is prohibited under section 1128B of the Social Security 
Act (42 U.S.C. 1320a–7b). 
‘‘(2) STATE LAW.—Nothing in this section shall be construed 
to occupy the field in which any provisions of this section 
operate to the exclusion of State laws on the same subject 
matter. 
‘‘(e) DEFINITIONS.—In this section— 
‘‘(1) the terms ‘applicable beneficiary’ and ‘applicable drug’ 
have the meanings given those terms in section 1860D–14A(g) 
of the Social Security Act (42 U.S.C. 1395w–114a(g)); 
‘‘(2) the term ‘clinical treatment facility’ means a medical 
setting , other than a hospital, that provides detoxification,
H. R. 6—217 
risk reduction, outpatient treatment and care, residential treat-
ment, or rehabilitation for substance use, pursuant to licensure 
or certification under State law; 
‘‘(3) the term ‘health care benefit program’ has the meaning 
given the term in section 24(b); 
‘‘(4) the term ‘laboratory’ has the meaning given the term 
in section 353 of the Public Health Service Act (42 U.S.C. 
263a); and 
‘‘(5) the term ‘recovery home’ means a shared living 
environment that is, or purports to be, free from alcohol and 
illicit drug use and centered on peer support and connection 
to services that promote sustained recovery from substance 
use disorders.’’. 
(b) CLERICAL AMENDMENT.—The table of sections for chapter 
11 of title 18, United States Code, is amended by inserting after 
the item related to section 219 the following: 
‘‘220. Illegal remunerations for referrals to recovery homes, clinical treatment facili-
ties, and laboratories.’’. 
Subtitle K—Substance Abuse Prevention 
SEC. 8201. SHORT TITLE. 
This subtitle may be cited as the ‘‘Substance Abuse Prevention 
Act of 2018’’. 
SEC. 8202. REAUTHORIZATION OF THE OFFICE OF NATIONAL DRUG 
CONTROL POLICY. 
(a) OFFICE OF NATIONAL DRUG CONTROL POLICY REAUTHORIZA-
TION ACT OF 1998.— 
(1) IN
GENERAL.—The Office of National Drug Control 
Policy Reauthorization Act of 1998 (21 U.S.C. 1701 et seq.), 
as in effect on September 29, 2003, and as amended by the 
laws described in paragraph (2), is revived and restored. 
(2) LAWS DESCRIBED.—The laws described in this paragraph 
are: 
(A) The Office of National Drug Control Policy 
Reauthorization Act of 2006 (Public Law 109–469; 120 
Stat. 3502). 
(B) The Presidential Appointment Efficiency and 
Streamlining Act of 2011 (Public Law 112–166; 126 Stat. 
1283). 
(b) REAUTHORIZATION.— 
(1) IN
GENERAL.—Section 714 of the Office of National 
Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1711) is amended by striking ‘‘such sums as may be necessary 
for each of fiscal years 2006 through 2010’’ and inserting 
‘‘$18,400,000 for each of fiscal years 2018 through 2023’’. 
(2) REPEAL OF TERMINATION.—The Office of National Drug 
Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701 
et seq.) is amended by striking section 715 (21 U.S.C. 1712). 
SEC. 8203. REAUTHORIZATION OF THE DRUG-FREE COMMUNITIES PRO-
GRAM. 
(a) REVIVAL
OF NATIONAL NARCOTICS LEADERSHIP ACT
OF 
1988.—
H. R. 6—218 
(1) IN
GENERAL.—Chapter 2 of the National Narcotics 
Leadership Act of 1988 (21 U.S.C. 1521 et seq.), except for 
subchapter II (21 U.S.C. 1541 et seq.), as in effect on September 
29, 1997, and as amended by the laws described in paragraph 
(2), is revived and restored. 
(2) LAWS DESCRIBED.—The laws described in this paragraph 
are: 
(A) Public Law 107–82 (115 Stat. 814). 
(B) The Office of National Drug Control Policy 
Reauthorization Act of 2006 (Public Law 109–469: 120 
Stat. 3502), as amended by paragraph (4). 
(3) AMENDMENT TO TERMINATION PROVISION.—Section 1009 
of the National Narcotics Leadership Act of 1988 (21 U.S.C. 
1056) is amended by inserting ‘‘and sections 1021 through 
1035’’ after ‘‘section 1007’’. 
(4) TECHNICAL CORRECTION.— 
(A) IN GENERAL.—Title VIII of the Office of National 
Drug Control Policy Reauthorization Act of 2006 (Public 
Law 109–469; 120 Stat. 3535) is amended by striking 
‘‘Drug-Free Communities Act of 1997’’ each place it appears 
and inserting ‘‘National Narcotics Leadership Act of 1988’’. 
(B) EFFECTIVE
DATE.—The amendments made by 
subparagraph (A) shall take effect as though enacted as 
part of the Office of National Drug Control Policy Reauthor-
ization Act of 2006 (Public Law 109–469; 120 Stat. 3502). 
(b) AMENDMENT TO NATIONAL NARCOTICS LEADERSHIP ACT OF 
1988.—Chapter 2 of subtitle A of title I of the National Narcotics 
Leadership Act of 1988 (21 U.S.C. 1521 et seq.) is amended— 
(1) in section 1022 (21 U.S.C. 1522), by striking ‘‘substance 
abuse’’ each place it appears and inserting ‘‘substance use and 
misuse’’; 
(2) in section 1023 (21 U.S.C. 1523), by striking paragraph 
(9) and inserting the following: 
‘‘(9) SUBSTANCE
USE
AND
MISUSE.—The term ‘substance 
use and misuse’ means— 
‘‘(A) the illegal use or misuse of drugs, including sub-
stances for which a listing is effect under any of schedules 
I through V under section 202 of the Controlled Substances 
Act (21 U.S.C. 812); 
‘‘(B) the misuse of inhalants or over-the-counter drugs; 
or 
‘‘(C) the use of alcohol, tobacco, or other related product 
as such use is prohibited by State or local law.’’; 
(3) in section 1024 (21 U.S.C. 1524), by striking subsections 
(a) and (b) and inserting the following: 
‘‘(a) IN GENERAL.—There is authorized to be appropriated to 
the Office of National Drug Control Policy to carry out this chapter 
$99,000,000 for each of fiscal years 2018 through 2023. 
‘‘(b) ADMINISTRATIVE COSTS.—Not more than 8 percent of the 
funds appropriated to carry out this chapter may be used by the 
Office of National Drug Control Policy to pay administrative costs 
associated with the responsibilities of the Office under this 
chapter.’’; 
(4) in subchapter I (21 U.S.C. 1531 et seq.)— 
(A) by striking ‘‘substance abuse’’ each place it appears 
and inserting ‘‘substance use and misuse’’; and
H. R. 6—219 
(B) in section 1032(b)(1)(A) (21 U.S.C. 1532(b)(1)(A)), 
by striking clause (iii) and inserting the following: 
‘‘(iii) RENEWAL GRANTS.—Subject to clause (iv), the 
Administrator may award a renewal grant to a grant 
recipient under this subparagraph for each fiscal year 
of the 4-fiscal-year period following the first fiscal year 
for which the initial additional grant is awarded in 
an amount not to exceed the following: 
‘‘(I) For the first and second fiscal years of 
the 4-fiscal-year period, the amount of the non- 
Federal funds, including in-kind contributions, 
raised by the coalition for the applicable fiscal 
year is not less than 125 percent of the amount 
awarded. 
‘‘(II) For the third and fourth fiscal tears of 
the 4-fiscal-year period, the amount of the non- 
Federal funds, including in-kind contributions, 
raised by the coalition for the applicable fiscal 
year is not less than 150 percent of the amount 
awarded.’’; and 
(5) by striking subchapter II (21 U.S.C. 1541 et seq.). 
SEC. 8204. REAUTHORIZATION OF THE NATIONAL COMMUNITY ANTI- 
DRUG COALITION INSTITUTE. 
Section 4 of Public Law 107–82 (21 U.S.C. 1521 note) is 
amended to read as follows: 
‘‘SEC. 4. AUTHORIZATION FOR NATIONAL COMMUNITY ANTIDRUG 
COALITION INSTITUTE. 
‘‘(a) IN GENERAL.—The Director shall, using amounts author-
ized to be appropriated by subsection (d), make a competitive grant 
to provide for the continuation of the National Community Anti- 
drug Coalition Institute. 
‘‘(b) ELIGIBLE ORGANIZATIONS.—An organization eligible for the 
grant under subsection (a) is any national nonprofit organization 
that represents, provides technical assistance and training to, and 
has special expertise and broad, national-level experience in commu-
nity antidrug coalitions under this subchapter. 
‘‘(c) USE OF GRANT AMOUNT.—The organization that receives 
the grant under subsection (a) shall continue a National Community 
Anti-Drug Coalition Institute to— 
‘‘(1) provide education, training, and technical assistance 
for coalition leaders and community teams, with emphasis on 
the development of coalitions serving economically disadvan-
taged areas; 
‘‘(2) develop and disseminate evaluation tools, mechanisms, 
and measures to better assess and document coalition perform-
ance measures and outcomes; and 
‘‘(3) bridge the gap between research and practice by trans-
lating knowledge from research into practical information. 
‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—The Director shall, 
using amounts authorized to be appropriated by section 1032 of 
the National Narcotics Leadership Act of 1988 (15 U.S.C. 1532), 
make a grant of $2 million under subsection (a), for each of the 
fiscal years 2018 through 2023.’’.